Arif, Muhammad

Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning ( vol 83 , 104214 , 2022)

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases (Retraction of Vol 314, art no 121325, 2023)

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

Genotypic Performance of F_4:7 Wheat Lines under Irrigated and Rainfed Conditions

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Discovery of therapeutic agents targeting <i>PKLR </i>for <i>NAFLD </i>using drug repositioning

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic liver disease

Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis

Multi-omics approaches for revealing the complexity of cardiovascular disease

Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer's and Parkinson's Diseases

Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning

iNetModels 2.0: an interactive visualization and database of multi-omics data

Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19

Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction

Discovery of Functional Alternatively Spliced <i>PKM</i> Transcripts in Human Cancers